- Home
- PTGX vs SGHC Comparison
PTGX vs SGHC Comparison
Compare PTGX & SGHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PTGX | SGHC |
|---|---|---|
| Founded | 2006 | 2020 |
| Country | United States | Guernsey |
| Employees | 141 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Services-Misc. Amusement & Recreation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.3B | 7.1B |
| IPO Year | 2016 | 2021 |
Fundamental Metrics
Financial Performance| Metric | PTGX | SGHC |
|---|---|---|
| Price | $143.59 | $12.73 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 13 | 6 |
| Target Price | ★ $108.23 | $17.33 |
| AVG Volume (30 Days) | 465.5K | ★ 2.3M |
| Earning Date | 05-07-2026 | 05-11-2026 |
| Dividend Yield | N/A | ★ 3.52% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.35 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $874.25 | $16.09 |
| Revenue Next Year | N/A | $9.73 |
| P/E Ratio | $61.15 | ★ $20.80 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $61.95 | $8.46 |
| 52 Week High | $160.81 | $15.86 |
Technical Indicators
Market Signals| Indicator | PTGX | SGHC |
|---|---|---|
| Relative Strength Index (RSI) | 45.56 | 33.95 |
| Support Level | $141.95 | $12.46 |
| Resistance Level | $160.81 | $13.02 |
| Average True Range (ATR) | 5.12 | 0.41 |
| MACD | -0.99 | -0.11 |
| Stochastic Oscillator | 26.15 | 10.95 |
Price Performance
Historical ComparisonAbout PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a biopharmaceutical company engaged in the discovery and development of peptide-based therapeutics using its proprietary technology platform. The company focuses on three therapeutic areas: inflammation and immunology, hematology, and metabolic diseases. Its pipeline includes clinical-stage and preclinical candidates such as rusfertide for polycythemia vera, icotrokinra for inflammatory diseases, and other programs targeting IL-17, obesity, and iron metabolism disorders, developed through internal research and strategic collaborations.
About SGHC Super Group (SGHC) Limited
Super Group (SGHC) Ltd is a holding company that operates online sports betting and gaming businesses. The company's four operating segments-Betway, Spin, Jumpman and DGC. A majority of its revenue is generated from the Betway segment, which is a single-brand online sports betting and casino offering with licenses to operate throughout Europe, the Americas, and Africa. Spin is the company's multi-brand online casino offering, having a diverse portfolio of casino brands such as Jackpot City, Spin Casino, Dream Bingo, Mirror Bingo, etc., designed to be culturally relevant globally while aiming to offer a wide range of casino products. Geographically, the company generates maximum revenue from Africa and Middle East, followed by North America, Europe, Asia-Pacific, and South/Latin America.